FDA again delays review of Amicus rare disease drug

Submitted by admin on October 31, 2022 - 4:11pm

Source:

BioPharma Dive

News Tags:

Amicus Therapeutics

Pompe disease

China

FDA

AT-GAA

Headline:

FDA again delays review of Amicus rare disease drug

snippet:

The Food and Drug Administration has for a second time this year delayed its review of Amicus Therapeutics’ experimental treatment for Pompe disease, deferring action until the agency can inspect the drug’s manufacturing facilities in China.

Search form

You are here

FDA again delays review of Amicus rare disease drug

FDA again delays review of Amicus rare disease drug